Page last updated: 2024-10-27

fluorouracil and Dermatitis Exfoliativa

fluorouracil has been researched along with Dermatitis Exfoliativa in 5 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"The management of patients with advanced colorectal cancer remains dependent on the optimal use of 5-Fluorouracil (5-FU)."9.07Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer. ( Carter, R; Cunningham, D; Evans, C; Findlay, M; Ford, H; Hill, A; Husband, J; Nicolson, M; Norman, A, 1994)
"The management of patients with advanced colorectal cancer remains dependent on the optimal use of 5-Fluorouracil (5-FU)."5.07Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer. ( Carter, R; Cunningham, D; Evans, C; Findlay, M; Ford, H; Hill, A; Husband, J; Nicolson, M; Norman, A, 1994)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuda, K1
Namiki, T1
Ueno, M1
Hashimoto, T1
Hanafusa, T1
Yokozeki, H1
SULLIVAN, RD1
ZUREK, WZ1
Findlay, M1
Hill, A1
Cunningham, D1
Norman, A1
Nicolson, M1
Ford, H1
Husband, J1
Evans, C1
Carter, R1
Vukelja, SJ1
Lombardo, FA1
James, WD1
Weiss, RB1
Atkins, JN1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multicentre Randomized Phase II Study of Neoadjuvant Trastuzumab Plus Docetaxel With and Without Bevacizumab and Trastuzumab Plus Docetaxel Plus Non-pegylated Liposome-encapsulated Doxorubicin (NPLD) With and Without Bevacizumab in HER2-positive Early Bre[NCT01367028]Phase 2100 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for fluorouracil and Dermatitis Exfoliativa

ArticleYear
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms

1994

Other Studies

4 other studies available for fluorouracil and Dermatitis Exfoliativa

ArticleYear
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
    European journal of dermatology : EJD, 2017, 06-01, Volume: 27, Issue:3

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neop

2017
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
    Cancer chemotherapy reports, 1964, Volume: 37

    Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf

1964
Pyridoxine for the palmar-plantar erythrodysesthesia syndrome.
    Annals of internal medicine, 1989, Oct-15, Volume: 111, Issue:8

    Topics: Dermatitis, Exfoliative; Fluorouracil; Hand Dermatoses; Humans; Male; Middle Aged; Nervous System Di

1989
Fluorouracil and the palmar-plantar erythrodysesthesia syndrome.
    Annals of internal medicine, 1985, Volume: 102, Issue:3

    Topics: Dermatitis, Exfoliative; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged

1985